SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 85 filers reported holding SAVARA INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $170,418 | +45.3% | 45,084 | +22.9% | 0.00% | 0.0% |
| Q2 2023 | $117,247 | +102.2% | 36,697 | +30.8% | 0.00% | – |
| Q1 2021 | $58,000 | +81.2% | 28,064 | +0.3% | 0.00% | – |
| Q4 2020 | $32,000 | +3.2% | 27,989 | -2.8% | 0.00% | – |
| Q3 2020 | $31,000 | -56.3% | 28,792 | +1.4% | 0.00% | – |
| Q2 2020 | $71,000 | +61.4% | 28,390 | +38.2% | 0.00% | – |
| Q1 2020 | $44,000 | -54.6% | 20,538 | -5.5% | 0.00% | – |
| Q4 2019 | $97,000 | +67.2% | 21,725 | -0.8% | 0.00% | – |
| Q3 2019 | $58,000 | +20.8% | 21,907 | +8.5% | 0.00% | – |
| Q2 2019 | $48,000 | -64.4% | 20,199 | +10.5% | 0.00% | -100.0% |
| Q1 2019 | $135,000 | -5.6% | 18,274 | -3.1% | 0.00% | 0.0% |
| Q4 2018 | $143,000 | -32.5% | 18,866 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $212,000 | +15.2% | 19,011 | +16.8% | 0.00% | 0.0% |
| Q2 2018 | $184,000 | – | 16,281 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 3,313,602 | $12,525,416 | 47.59% |
| NEA Management Company, LLC | 24,471,264 | $92,501,378 | 7.14% |
| Bain Capital Life Sciences Investors, LLC | 14,232,751 | $53,799,799 | 6.02% |
| TCG Crossover Management, LLC | 10,000,000 | $37,800,000 | 5.57% |
| VR Adviser, LLC | 7,184,865 | $27,158,790 | 2.86% |
| Affinity Asset Advisors, LLC | 1,150,000 | $4,347,000 | 1.22% |
| Sio Capital Management, LLC | 896,250 | $3,387,825 | 1.05% |
| Frazier Life Sciences Management, L.P. | 4,000,000 | $15,120,000 | 1.00% |
| Vivo Capital, LLC | 1,913,349 | $7,232,459 | 0.79% |
| Nantahala Capital Management | 1,039,364 | $3,928,796 | 0.34% |